{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:14:02Z","timestamp":1770822842479,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.bulcan.2025.09.002","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T20:22:34Z","timestamp":1764188554000},"page":"260-272","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Toxicit\u00e9 digestive \u00ab\u00a0sup\u00e9rieure\u00a0\u00bb de l\u2019immunoth\u00e9rapie"],"prefix":"10.1016","volume":"113","author":[{"given":"Justine","family":"Vivier Chicoteau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucie","family":"Thibault","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pauline","family":"Vaflard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pauline","family":"Du Rusquec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romain","family":"Seban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Daniel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascale","family":"Mariani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delphine","family":"Loirat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Buecher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bulcan.2025.09.002_bib0130","series-title":"Management of Immunotherapy-Related Toxicities Version 1.2025","year":"2024"},{"issue":"12","key":"10.1016\/j.bulcan.2025.09.002_bib0135","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.annonc.2022.10.001","article-title":"Management of toxicities from\u00a0immunotherapy:\u00a0ESMO\u00a0Clinical Practice Guideline for diagnosis, treatment and follow-up. ESMO Guidelines Committee","volume":"33","author":"Haanen","year":"2022","journal-title":"Ann Oncol"},{"key":"10.1016\/j.bulcan.2025.09.002_bib0140","unstructured":"Institut national du cancer. Recommandations et r\u00e9f\u00e9rentiels. R\u00e9f\u00e9rentiels de bonnes pratiques. Pr\u00e9vention et gestion des effets ind\u00e9sirables des anticanc\u00e9reux. Immunoth\u00e9rapies: inhibiteurs de points de contr\u00f4le immunitaire. https:\/\/www.cancer.fr."},{"issue":"5","key":"10.1016\/j.bulcan.2025.09.002_bib0145","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1080\/00365521.2019.1594356","article-title":"Upper gastrointestinal symptoms and associated endoscopic and histological features in patients receiving immune checkpoint inhibitors","volume":"54","author":"Tang","year":"2019","journal-title":"Scan J Gastroenterol"},{"key":"10.1016\/j.bulcan.2025.09.002_bib0150","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/his.13963","article-title":"Immune-related adverse events in the gastrointestinal tract: diagnostic utility of upper gastrointestinal biopsies","volume":"76","author":"Zhang","year":"2020","journal-title":"Histopathology"},{"issue":"12","key":"10.1016\/j.bulcan.2025.09.002_bib0155","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1111\/jgh.16349","article-title":"Serious immune-related upper gastrointestinal toxicity of immune checkpoint inhibitors: a multicenter case series","volume":"38","author":"Bresteau","year":"2023","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.bulcan.2025.09.002_bib0160","doi-asserted-by":"crossref","first-page":"2408852","DOI":"10.1080\/21645515.2024.2408852","article-title":"A systematic review of gastritis as an immune-related adverse event in clinical interventions","volume":"20","author":"Su","year":"2024","journal-title":"Hum Vaccines Immunother"},{"issue":"10","key":"10.1016\/j.bulcan.2025.09.002_bib0165","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1007\/s12094-022-02840-9","article-title":"Diagnostic impact of 18-FDG PET\/CT imaging on the detection of immune-related adverse events in patients treated with immunotherapy","volume":"24","author":"Tatar","year":"2022","journal-title":"Clin Transl Oncol"},{"issue":"2","key":"10.1016\/j.bulcan.2025.09.002_bib0170","doi-asserted-by":"crossref","first-page":"191","DOI":"10.5858\/arpa.2019-0700-OA","article-title":"Immune checkpoint inhibitor-induced upper gastrointestinal tract inflammation shows morphologic similarities to, but is immunologically distinct from, helicobacter pylori gastritis and celiac disease","volume":"145","author":"Irshaid","year":"2021","journal-title":"Arch Pathol Lab Med"},{"issue":"6","key":"10.1016\/j.bulcan.2025.09.002_bib0175","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1007\/s10620-020-06440-x","article-title":"Gastroparesis\u00a0following immune checkpoint inhibitor therapy: a case series","volume":"66","author":"Atieh","year":"2021","journal-title":"Dig Dis Sci"},{"issue":"1","key":"10.1016\/j.bulcan.2025.09.002_bib0180","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-000958","article-title":"Immune checkpoint inhibitor-associated celiac disease","volume":"8","author":"Badran","year":"2020","journal-title":"J Immunother Cancer"},{"issue":"1","key":"10.1016\/j.bulcan.2025.09.002_bib0185","doi-asserted-by":"crossref","first-page":"59","DOI":"10.14309\/ajg.0000000000002075","article-title":"American College of AGAstroenterology guidelines update: diagnosis and management of celiac disease","volume":"118","author":"Rubio-Tapia","year":"2023","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.bulcan.2025.09.002_bib0190","doi-asserted-by":"crossref","first-page":"571","DOI":"10.5858\/arpa.2020-0070-RA","article-title":"Pathologic manifestations of gastrointestinal and hepatobiliary injury in immune checkpoint inhibitor therapy","volume":"145","author":"Patil","year":"2021","journal-title":"Arch Pathol Lab Med"},{"issue":"6","key":"10.1016\/j.bulcan.2025.09.002_bib0195","first-page":"e39920","article-title":"Immune checkpoint inhibitor-induced lymphocytic esophagitis","volume":"15","author":"Amin","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.bulcan.2025.09.002_bib0200","first-page":"100029","article-title":"Checkpoint inhibitor induced esophagitis with documented resolution on infliximab","volume":"2","author":"Chen","year":"2020","journal-title":"Curr Probl Cancer Case Rep"},{"issue":"8","key":"10.1016\/j.bulcan.2025.09.002_bib0205","doi-asserted-by":"crossref","first-page":"896","DOI":"10.6004\/jnccn.2020.7675","article-title":"Clinicopathologic features, treatment response, and outcomes of immune checkpoint inhibitor-related esophagitis","volume":"19","author":"Panneerselvam","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"10.1016\/j.bulcan.2025.09.002_bib0210","doi-asserted-by":"crossref","first-page":"e01252","DOI":"10.14309\/crj.0000000000001252","article-title":"Severe dysphagia with eosinophilic esophagitis pattern of injury related to pembrolizumab therapy","volume":"11","author":"Barnett","year":"2024","journal-title":"ACG Case Rep J"},{"issue":"1","key":"10.1016\/j.bulcan.2025.09.002_bib0215","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1177\/10781552231203723","article-title":"Camrelizumab-induced oral lichenoid reaction with subepithelial CD4+ T-cell infiltration","volume":"30","author":"Wang","year":"2024","journal-title":"J Oncol Pharm Pract"},{"issue":"9","key":"10.1016\/j.bulcan.2025.09.002_bib0220","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/CJI.0000000000000381","article-title":"Esophageal\u00a0achalasia\u00a0induced by ipilimumab and nivolumab combination: a rare neurological manifestation of immune-related autonomic neuropathy","volume":"44","author":"Montes","year":"2021","journal-title":"J Immunother"},{"key":"10.1016\/j.bulcan.2025.09.002_bib0225","doi-asserted-by":"crossref","first-page":"100083","DOI":"10.1016\/j.esmogo.2024.100083","article-title":"A new classification of upper gastrointestinal toxicity induced by immunotherapy: from endoscopic and pathological insights to clinical management","volume":"5","author":"Casadio","year":"2024","journal-title":"ESMO Gastrointest Oncol"},{"issue":"14","key":"10.1016\/j.bulcan.2025.09.002_bib0230","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.3748\/wjg.v30.i14.1941","article-title":"Immune checkpoint inhibitor-associated gastritis: patterns ANS management","volume":"30","author":"Lin","year":"2024","journal-title":"World J Gastroenterol"},{"issue":"4","key":"10.1016\/j.bulcan.2025.09.002_bib0235","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/1750743X.2025.2473305","article-title":"Gastrointestinal toxicities associated with immune checkpoint inhibitors therapy: risks and management","volume":"17","author":"Colli Cruz","year":"2025","journal-title":"Immunotherapy"},{"issue":"24","key":"10.1016\/j.bulcan.2025.09.002_bib0240","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.3748\/wjg.v30.i24.3123","article-title":"Gastric microbiota transplantation as a potential tretment for immune checkpoint inhibitor-associated gastritis","volume":"30","author":"Ma","year":"2024","journal-title":"World J Gastroenterol"},{"issue":"700","key":"10.1016\/j.bulcan.2025.09.002_bib0245","doi-asserted-by":"crossref","first-page":"eabq4006","DOI":"10.1126\/scitranslmed.abq4006","article-title":"Microbiome alteration via fecal microbiota transplantation is effective for refractory immune checkpoint inhibitor-induced\u00a0colitis","volume":"15","author":"Halsey","year":"2023","journal-title":"Sci Transl Med"},{"issue":"3","key":"10.1016\/j.bulcan.2025.09.002_bib0125","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/MOG.0000000000000515","article-title":"Demystifying autoimmune small bowel\u00a0enteropathy","volume":"35","author":"Elli","year":"2019","journal-title":"Curr Opin Gastroenterol"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455125004448?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455125004448?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T14:30:09Z","timestamp":1770820209000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455125004448"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S0007455125004448"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2025.09.002","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Toxicit\u00e9 digestive \u00ab\u00a0sup\u00e9rieure\u00a0\u00bb de l\u2019immunoth\u00e9rapie","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2025.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}